Peer-influenced content. Sources you trust. No registration required. This is HCN.

Epoch HealthNew Federal AI Project Could Help Create Cancer mRNA Vaccine, Oracle CEO Says

A new federal artificial intelligence initiative, called Stargate, will receive up to $500 billion in investment for AI infrastructure development in the United States. Oracle CEO Larry Ellison highlighted the project’s potential application in developing personalized mRNA cancer vaccines, suggesting a 48-hour turnaround time from detection to vaccine production using AI-driven processes and robotics.


Key Points:

  • The White House announced a partnership with major tech companies including Oracle, Microsoft, NVIDIA, and OpenAI, starting with an initial $100 billion investment that could expand to $500 billion
  • Oracle CEO Larry Ellison described an AI-enabled blood testing system for early cancer detection, coupled with rapid personalized mRNA vaccine production within 48 hours
  • The project anticipates creating more than 100,000 American jobs “almost immediately,” according to the announcement
  • SoftBank CEO Masayoshi Son committed $100 billion to US projects over the next four years, building on previous investments
  • Tesla CEO Elon Musk questioned the financial backing, stating SoftBank has “well under $10B secured”

“You can make that vaccine, that mRNA vaccine, you can make that robotically, again using AI, in about 48 hours. So imagine early cancer detection, the development of a cancer vaccine for your particular cancer, aimed at you, and have that vaccine available in 48 hours.”
— Larry Ellison, Oracle CEO


Personalized Medicine Summaries

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form